Valerie Martel-Laferriere

Author PubWeight™ 5.26^‹?›

Rank	Title	Journal	Year	PubWeight™‹?›
1	Costs of telaprevir-based triple therapy for hepatitis C: $189,000 per sustained virological response.	Hepatology	2014	1.05
2	Mortality in HIV-hepatitis C co-infected patients in Canada compared to the general Canadian population (2003-2013).	AIDS	2014	0.98
3	Clinical factors that predict noncirrhotic portal hypertension in HIV-infected patients: a proposed diagnostic algorithm.	J Infect Dis	2013	0.94
4	Vibrio cholerae in traveler from Haiti to Canada.	Emerg Infect Dis	2011	0.85
5	Septic bursitis, a potential complication of protease inhibitor use in hepatitis C virus.	Clin Infect Dis	2013	0.77
6	Hepatocellular carcinoma in a noncirrhotic patient with HIV: a case report and review of the literature.	Semin Liver Dis	2012	0.76
7	Antiretroviral and anti-hepatitis C virus direct-acting antiviral-related hepatotoxicity.	Clin Liver Dis	2013	0.75
8	Successful desensitization to ribavirin in a patient with chronic hepatitis C.	J Clin Gastroenterol	2012	0.75